Oral cancer begins as a precancerous lesion. If a lesion does not heal in four weeks, FA individuals are advised to consult with an otolaryngologist (ENT physician). If the lesion appears suspicious, the physician often performs a biopsy. Could precancerous...
Announcements
To the Fanconi anemia community, I am writing to inform you that, due to the global health crisis, the Fanconi Anemia Research Fund (FARF) has made the very difficult decision to not move forward with the in-person 2020 Scientific Symposium and Meeting for...
Announcements
MARCH 13: Due to the ever-evolving impact of the coronavirus pandemic, FARF staff will be working remotely for the next few weeks. While we are equipped with the necessary technology to continue meeting our mission and providing service, this will...
Announcements
Read about Dr. D'Andrea's FARF-funded research projects At the 2019 FARF Scientific Symposium, Dr. D’Andrea was presented with the Lifetime Achievement Award for dedicating his career to the advancement of Fanconi anemia research. Dr. D’Andrea has been a pillar of...
Announcements
Fanconi anemia (FA) is associated with progressive bone marrow failure, cancer predisposition, and multiple congenital abnormalities. Brain atrophy and other abnormalities of the brain have also been reported, although the cause of these abnormalities and recommendations for clinical care are...
Announcements
Aldehydes, including acetaldehyde and formaldehyde, can cause DNA damage by inducing DNA interstrand crosslinks, which cause damage to hematopoietic stem cells, leading to bone marrow failure and cancer in people with Fanconi anemia (FA). Exposure to aldehydes is inevitable and...
Announcements
